Intuitive Surgical (ISRG) CMO’s trust sells 526 shares after awards vest

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) executive Myriam Curet reported option exercises, RSU vesting, and related share sales through a trust. On February 10, 2026, a trust associated with Curet acquired 838 common shares from vested RSUs and 105 shares via stock option exercise, and disposed of 417 shares to cover taxes. The trust also sold 105 shares at $494.65 on February 10 and 421 shares at $494.96 on February 11 in open-market transactions under a Rule 10b5-1 trading plan. Following these transactions, the trust held 409 common shares, while Curet directly held derivative positions including 1,257 stock options and 838 RSUs subject to the disclosed vesting schedules.

Insights

Equity compensation and insider-transactions analyst

Routine equity vesting and planned sales by a trust linked to ISRG’s CMO.

These transactions show Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, managing existing equity awards. RSUs vested into 838 common shares and 105 option shares were exercised, with part of the stock withheld to satisfy tax obligations.

The trust associated with Curet then executed open-market sales of 105 and 421 shares at prices around $494 per share. A key detail is that the sales followed a Rule 10b5-1 trading plan that expires on July 29, 2026, indicating they were pre-arranged rather than discretionary.

After the trades, the trust held 409 shares, while derivative holdings included 1,257 options and 838 RSUs with time-based vesting from February 10, 2023. Overall, this appears to be standard equity compensation activity rather than a signal of a strategic shift.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		M(1)		838	A	$0.0	1,247	I	by Trust
Common Stock	02/10/2026		F(1)		417	D	$492.84	830	I	by Trust
Common Stock	02/10/2026		M(2)		105	A	$229.39	935	I	by Trust
Common Stock	02/10/2026		S(2)		105	D	$494.65	830	I	by Trust
Common Stock	02/11/2026		S(2)		421	D	$494.96	409	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$229.39	02/10/2026		M(2)			105	(3)	02/27/2030	Common Stock	105	$0.0	1,257	D
Restricted Stock Units	$0.0	02/10/2026		M			838	(4)	(4)	Common Stock	838	$0.0	838	D

Explanation of Responses:

1. RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

2. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

3. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

4. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.